Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients.
Theresa BurkardRoss D WilliamsEnriqueta Vallejo-YagüeThomas HügleAxel FinckhDiego KyburzAndrea Michelle BurdenPublished in: Rheumatology advances in practice (2021)
Our results suggest that models with up to eight unique variables may predict sustained b/tsDMARD-free remission with good efficiency. External validation is warranted.